IGAS Energy (LSE: IGAS), Standard Chartered (LSE: STAN), and Sainsbury’s (LSE: SBRY) — three different investments, all trading close to their one-year lows. If you smell a bargain, here are a few things you ought to consider before snapping them up.
Weakness
I have always been bearish on IGAS and I haven’t made up my mind as yet, but I acknowledge that at 20p a share this shale gas developer has become particularly tempting.
When it announced its final results on 26 June IGAS traded around 26p, but market volatility has meant value deterioration for a company whose latest financials aren’t particularly promising — cash is down, net debt is up, revenues are falling and losses are widening. Still, it has close relationships with such partners such as Total E&P UK, GDF Suez E&P UK and Ineos. So, the bulls could argue, if it gets in trouble it will likely be bailed out!
Should you invest £1,000 in AstraZeneca right now?
When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if AstraZeneca made the list?
After all, it could easily attract a bid: its price-to-book value signals stress and its stock is dirt cheap, given that it trades close to the low end of its 52-week range (18.25p-92.75p). However, that’s not a good enough reason to buy.
Lack of trust
Another stock that reminds me a of stressed bond is Sainsbury’s. It trades at 226p, which is very close to the low end of its 52-week range of 221.1p–288.4p.
The food retailer bears the hallmarks of an appealing investment based on trading multiples and net worth metrics. The problem, as you might know, is that trust has gone out of the window in the food retail sector and a huge amount of pressure is being felt on trading profits and core margins. Recent market share figures show that Sainsbury’s is holding up relatively well, at least compared to Tesco and Morrisons , and at 10x its forward earnings you’d be buying a stock that trades at a discount of about 40% against the FTSE 100‘s long-term average.
The real problem is that nobody can firmly say if or when market share erosion will stop and whether the current business model of the top four food retailers in the UK is destined to live or die. Tesco is shrinking, while Morrisons recently offloaded its convenience stores, but no-frills discounters Aldi and Lidl continue to invest in organic growth, gaining share. I’d argue that whilst Sainsbury is certainly not safe yet, it’s a safer investment than Standard Chartered — but I’d rather buy the shares of the latter if I were to embrace equity risk.
Exposed
Most trading metrics signal stress — and at 660p a share, Standard Chartered trades very close to the low end of its 52-week range (648.3p-1,174p). I think that its valuation already prices in the risk of a large cash call and another dividend cut, neither of which is strictly necessary, in my view, although certain analysts and pundits have argued in favour of a rights issues as big as $10bn to fix its balance sheet.
Market volatility, weakness in commodity prices and all sorts of speculations are killing the investment case, and it couldn’t be otherwise in the light of Standard Chartered’s exposure. I hold faith, however, in its new management team, while a few other elements suggest that this could easily become a stock to hold as part of a diversified portfolio — namely, restructuring potential, possible appetite for some of its assets and stronger corporate governance rules.
It’s not going to be easy but it could be worth it at this price.
